Locations:
Search
by Saqib Sachani, PhD, MBA, Director, Innovations Business Development and Licensing
As healthcare marches into 2025, the industry stands on the brink of pivotal changes. Venture funding for digital health is regaining momentum, particularly for solutions that modernize infrastructure, enhance care delivery, and empower patients. Todd Schwarzinger, MBA, Partner, Cleveland Clinic Innovations Ventures, shares insights on how new partnerships and technologies are reshaping the future of care.
At the forefront of biological therapeutics development, Feng Lin, PhD, of Cleveland Clinic is revolutionizing the field through groundbreaking research in antibody development and strategic industry partnerships. His work spans from innovative cancer treatments to complement-mediated disease therapies, marking a new era in biological therapeutic solutions.
By Mohamed Ramadan, PhD, MBA, General Manager, Cleveland Clinic Innovations Development
Cleveland Clinic developed Autism Eyes, an eye-tracking technology that detects autism markers by analyzing how children view images. Acquired in early 2024, this technology aims to reduce the typical one-to-three-year delay between noticing symptoms and receiving a formal autism diagnosis.
Cleveland Clinic Innovations (CCI) demonstrated exceptional performance in 2024, securing 144 patents, generating $27 million in licensing revenue, and investing $29 million in companies. The organization's achievements spanned technology development, international expansion, and capital raises, solidifying its position as a transformative force in healthcare innovation.
LifeArc and Cleveland Clinic sign 10-year Master Services Agreement to develop novel monoclonal antibody-based therapeutics, building on their successful collaboration since 2019. The agreement combines LifeArc's three decades of expertise in antibody humanization with Cleveland Clinic's renowned capabilities, aiming to address unmet medical needs in areas including cancer and complement-mediated diseases.
Gerald “Jerry” Wilmink, PhD, MBA, Director, Innovations Business Development and Licensing at Cleveland Clinic Innovations, joined Becker's to discuss how artificial intelligence is revolutionizing healthcare through synthetic data generation, enhanced specialist-generalist collaboration, and improved clinical decision-making capabilities.
JD Friedland shares his journey from investment banking to healthcare innovation leadership, offering insights into Cleveland Clinic Innovations' approach to balancing profitable growth with advancing patient care through strategic investments in digital health, medical devices, and life sciences.
In Cleveland Clinic Innovations’ latest Inventor Chronicle, discover how the Structured Innovation Challenge team "Sac it to ‘Em", featuring Linda Bradley, MD, Bradley Gill, MD, Cara King, DO, MS, Lindsey Valentine, MD, Liron Bar-El, MD, and Emily Frisch, MD, is streamlining specimen bagging with a revolutionary device that enhances efficiency and patient care.